Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

HENDERSON, Nev., July 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces it has demonstrated quantification of ...

As Covid infections reach a record high in the UK, many will be testing themselves to see if they have fallen victim to the virus. Even though free testing for millions has ended in England, testing ...

Further, the US held the majority share in the global lateral flow assays market and is likely to remain the leading region growing at a CAGR of 7.7% within this market, during the forecast period.